Logo

HR Pharmaceuticals and Poiesis Medical Sign a Deal for Dual Balloon Catheter Technology in North America

Share this
HR Pharmaceuticals

HR Pharmaceuticals and Poiesis Medical Sign a Deal for Dual Balloon Catheter Technology in North America

Shots:

  • HR Pharmaceuticals and Poiesis Medical have signed an exclusive commercialization agreement for the latter’s Dual Balloon Catheter (Duette) technology
  • As per the agreement, HR Pharmaceuticals obtains exclusive rights to commercialize the product in North America for addressing AEs associated with Foley catheterization, necessary for specific patient populations
  • The company anticipates the processing of Duette Dual Balloon Catheters orders from Jan 2, 2024 onwards

Ref: PR Newswire | Image: HR Pharmaceuticals

Related News:- YL Biologics Reports the NDA Submission of YLB217 (biosimilar product of long-acting erythropoiesis stimulating agent Nesp)

 

Click here to­ read the full press release 

Shivani Chandra

Shivani was a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She was covering news related to Product approvals, clinical trial results, and updates. We can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions